- Home
- RGNX vs GRVY Comparison
RGNX vs GRVY Comparison
Compare RGNX & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | GRVY |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 418.1M | 431.2M |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RGNX | GRVY |
|---|---|---|
| Price | $8.61 | $63.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.75 | N/A |
| AVG Volume (30 Days) | ★ 752.0K | 20.1K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | $50.05 | N/A |
| Revenue Next Year | $23.31 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.04 | $54.54 |
| 52 Week High | $16.19 | $74.75 |
Technical Indicators
Market Signals| Indicator | RGNX | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 48.67 | 50.39 |
| Support Level | $7.81 | $61.06 |
| Resistance Level | $9.28 | $65.00 |
| Average True Range (ATR) | 0.48 | 1.88 |
| MACD | 0.07 | 0.20 |
| Stochastic Oscillator | 67.76 | 73.32 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.